A novel mouse model of testicular granulosa cell tumors
A novel mouse model of testicular granulosa cell tumors
批准号:
10062490
负责人:
Qinglei Li
金额:
$7.31万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-12-01 至 2022-11-30
关键词:
AddressAgeAnimal ModelBiological AssayCell Differentiation processCellsCharacteristicsComplement Factor BCoupledDevelopmentDiagnosticDiseaseEmbryonic DevelopmentEtiologyFOXL2 geneGeneticGoalsGonadal structureGrowth FactorHumanIncidenceLightLinkMADH2 geneMalignant - descriptorMalignant NeoplasmsMissionMolecularMusMutationOvarian Granulosa Cell TumorPathogenesisPathway AnalysisPathway interactionsPatientsPhenotypePrognosisProteomicsPublishingRegulator GenesReportingResearchResearch DesignRoleScientistSex Cord-Gonadal Stromal TumorsSignal TransductionSomatic CellSurvival RateTestingTestisTherapeuticTherapeutic InterventionTransforming Growth Factor betaTransforming Growth Factor beta ReceptorsTransforming Growth FactorsTumor stageValidationbasecomparativedesigngene discoverygene functiongranulosa cellgranulosa cell tumorinsightmalemembermouse modelnovelnovel diagnosticsnovel therapeutic interventionprogramsreceptorreproductivesertoli cellstem cellstranscriptomicstransdifferentiationtumortumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Title: A novel mouse model of testicular granulosa cell tumors
PROJECT SUMMARY
Despite the relatively high 5-year survival rate of granulosa cell tumors (GCTs) in stage I
patients, poor prognosis is associated with patients at advanced tumor stage, justifying the need
to study this type of poorly defined tumors. Of note, GCTs may also arise from the testis with
low incidence. Thus, animal models are useful to investigate the pathogenesis of this disease.
Overactivation of transforming growth factor β (TGFβ) receptor 1 (TGFBR1) using Amhr2-Cre to
target mouse granulosa cells provokes the development of ovarian GCTs. It was found that
male mice develop testicular GCTs at an early age. The exciting phenotypic manifestation of
GCTs in the testes of these mice raised the question of how dysregulated TGFβ signaling
promotes testicular GCT formation. The central hypothesis is that dysregulation of TGFβ
signaling alters the differentiation program of Sertoli cells, promoting the transdifferentiation of
Sertoli cell to malignant granulosa cells characteristic of GCTs. This hypothesis is based on
compelling genetic evidence, and will be tested in a single aim by identifying mechanistic
underpinnings of testicular GCT development resulting from constitutive activation of TGFBR1.
A comprehensive approach combining transcriptomic and proteomic analyses will be utilized to
address the posed question. Results of this application are expected to provide a paradigm shift
for understanding gonadal tumorigenesis and reveal a novel link among growth factor signaling,
cell fate alteration, and oncogenesis. Therefore, completion of this proposal will have a
significant impact on the etiology of testicular GCTs. The findings have potential diagnostic and
therapeutic value for sex cord-stromal tumors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
UTX: A novel regulator of decidualization?
-
批准号:10390537
-
项目类别:
-
资助金额:$7.3万
-
财政年份:2022
-
负责人:Qinglei Li
-
依托单位:
UTX: A novel regulator of decidualization?
-
批准号:10570990
-
项目类别:
-
资助金额:$7.29万
-
财政年份:2022
-
负责人:Qinglei Li
-
依托单位:
TGF-BETA SIGNALING IN ENDOMETRIAL CELL FUNCTION AND DYSFUNCTION
-
批准号:9886078
-
项目类别:
-
资助金额:$30.44万
-
财政年份:2017
-
负责人:Qinglei Li
-
依托单位:
TGF-BETA SIGNALING IN ENDOMETRIAL CELL FUNCTION AND DYSFUNCTION
-
批准号:10112273
-
项目类别:
-
资助金额:$29.77万
-
财政年份:2017
-
负责人:Qinglei Li
-
依托单位:
Characterization of a novel mouse model with enhanced TGF-Beta signaling in the ovary
-
批准号:8968721
-
项目类别:
-
资助金额:$7.08万
-
财政年份:2015
-
负责人:Qinglei Li
-
依托单位:
TGF-BETA Signaling in Myometrial Development and Function
-
批准号:8358471
-
项目类别:
-
资助金额:$22.23万
-
财政年份:2012
-
负责人:Qinglei Li
-
依托单位:
TGF-BETA Signaling in Myometrial Development and Function
-
批准号:8523949
-
项目类别:
-
资助金额:$17.38万
-
财政年份:2012
-
负责人:Qinglei Li
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: